Phosphotyrosine Signaling Analysis in Human Tumors Is Confounded by Systemic Ischemia-Driven Artifacts and Intra-Specimen Heterogeneity
Aaron S. Gajadhar(Massachusetts Institute of Technology), Forest M. White(Center for Cancer Research), Alan J. Herline(Vanderbilt University), Douglas A. Levine(New York University), Kerry Wiles(Vanderbilt University Medical Center), Kent Shaddox(Breast Cancer Research Foundation), D.C. Liebler(National Institute of Standards and Technology), M. Kay Washington(Vanderbilt University Medical Center), Hannah Johnson(Massachusetts Institute of Technology), Robbert J.C. Slebos
Cited by 56
Related Papers
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k